{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:19:01Z","timestamp":1792423141020,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R24DA033211"],"award-info":[{"award-number":["R24DA033211"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009656","name":"Russian Academy of Medical Sciences","doi-asserted-by":"publisher","award":["R24DA033211"],"award-info":[{"award-number":["R24DA033211"]}],"id":[{"id":"10.13039\/100009656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.josat.2023.209055","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:06:51Z","timestamp":1682280411000},"page":"209055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder"],"prefix":"10.1016","volume":"150","author":[{"given":"Ashish P.","family":"Thakrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarratt D.","family":"Pytell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth B.","family":"Stoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Chander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.josat.2023.209055_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2S","key":"10.1016\/j.josat.2023.209055_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0000000000000633","article-title":"The ASAM National Practice Guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209055_bb0015","series-title":"Data & Demographics\u20142020 Census Data","year":"2021"},{"key":"10.1016\/j.josat.2023.209055_bb0020","article-title":"Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community","volume":"8","author":"Biondi","year":"2022","journal-title":"ClinicalPractice"},{"issue":"2","key":"10.1016\/j.josat.2023.209055_bb0025","first-page":"8","article-title":"Methadone and oral health \u2013 A brief","volume":"85","author":"Brondani","year":"2011","journal-title":"Review"},{"key":"10.1016\/j.josat.2023.209055_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2023.209055_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-8993(94)91738-8","article-title":"The role of multiple opioid receptors in the potentiation of reward by food restriction","volume":"639","author":"Carr","year":"1994","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/j.josat.2023.209055_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ADM.0000000000000635","article-title":"Executive summary of the focused update of the ASAM National Practice Guideline for the treatment of opioid use disorder","volume":"14","author":"Crotty","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209055_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11845-015-1314-5","article-title":"Demographic and clinical factors predicting retention in methadone maintenance: Results from an Irish cohort","volume":"185","author":"Darker","year":"2016","journal-title":"Irish Journal of Medical Science"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02287327","article-title":"Retention in publicly funded methadone maintenance treatment in two Western states","volume":"32","author":"Deck","year":"2005","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"6","key":"10.1016\/j.josat.2023.209055_bb0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.addbeh.2011.01.004","article-title":"Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness","volume":"36","author":"Deering","year":"2011","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2023.209055_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.drugalcdep.2015.02.007","article-title":"Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance","volume":"149","author":"Dhingra","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2023.209055_bb0065","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/1475-6773.12275","article-title":"Using grounded theory method to capture and analyze health care experiences","volume":"50","author":"Foley","year":"2015","journal-title":"Health Services Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"\u201cIt\u2019s like 'liquid handcuffs\u201d: The effects of take-home dosing policies on methadone maintenance treatment (MMT) patients\u2019 lives","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.josat.2023.209055_bb0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamapsychiatry.2022.0004","article-title":"Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic","volume":"79","author":"Friedman","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2023.209055_bb0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/154405910408300508","article-title":"Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults","volume":"83","author":"G\u00f6trick","year":"2004","journal-title":"Journal of Dental Research"},{"issue":"2","key":"10.1016\/j.josat.2023.209055_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.2010.03159.x","article-title":"Decreased bone density in men on methadone maintenance therapy: Bone density during methadone therapy","volume":"106","author":"Grey","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209055_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108655","article-title":"\u201cNo home to take methadone to\u201d: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston","volume":"135","author":"Harris","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209055_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108801","article-title":"Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis","volume":"141","author":"Hoffman","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2023.209055_bb0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-244X-12-238","article-title":"Methadone treatments in a Swiss region, 2001\u20132008: A registry-based analysis","volume":"12","author":"Huissoud","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.josat.2023.209055_bb0110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapsychiatry.2022.1776","article-title":"Methadone-involved overdose deaths in the US before and after Federal Policy Changes Expanding Take-Home Methadone Doses from Opioid Treatment Programs","volume":"79","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.josat.2023.209055_bb0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.05.027","article-title":"Low bone density in patients receiving methadone maintenance treatment","volume":"85","author":"Kim","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2023.209055_bb0120","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/ADM.0000000000000981","article-title":"Shifting medication treatment practices in the COVID-19 pandemic: A statewide survey of Pennsylvania opioid treatment programs","volume":"16","author":"Krawczyk","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209055_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019","author":"Krawczyk","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: Review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction (Abingdon, England)"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13722-021-00281-3","article-title":"Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: A qualitative thematic analysis","volume":"16","author":"Levander","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/08897077.2021.1986768","article-title":"COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership","volume":"43","author":"Levander","year":"2022","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.josat.2023.209055_bb0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/dar.13049","article-title":"Understanding concurrent stimulant use among people on methadone: A qualitative study","volume":"39","author":"McNeil","year":"2020","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.josat.2023.209055_bb0150","series-title":"Medications for Opioid Use Disorder Save Lives","year":"2019"},{"key":"10.1016\/j.josat.2023.209055_bb0155","article-title":"Principles of drug addiction treatment: A research-based guide: Third edition: (686332012\u2013001) [Data set]","year":"2012","journal-title":"American Psychological Association"},{"issue":"5","key":"10.1016\/j.josat.2023.209055_bb0160","article-title":"Retention of patients in opioid substitution treatment: A systematic review","volume":"15","author":"O'Connor","year":"2020","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.josat.2023.209055_bb0165","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1037\/adb0000090","article-title":"Predictors of patient retention in methadone maintenance treatment","volume":"29","author":"Proctor","year":"2015","journal-title":"Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.josat.2023.209055_bb0170","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7150\/ijms.52201","article-title":"Factors associated with low bone density in opioid substitution therapy patients: A systematic review","volume":"18","author":"Ramli","year":"2021","journal-title":"International Journal of Medical Sciences"},{"issue":"4","key":"10.1016\/j.josat.2023.209055_bb0175","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/ADM.0000000000000584","article-title":"Comparing reasons for starting and stopping methadone, buprenorphine, and naltrexone treatment among a sample of white individuals with opioid use disorder","volume":"14","author":"Randall-Kosich","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209055_bb0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02791072.2009.10400539","article-title":"Premature discharge from methadone treatment: Patient perspectives","volume":"41","author":"Reisinger","year":"2009","journal-title":"Journal of Psychoactive Drugs"},{"issue":"10","key":"10.1016\/j.josat.2023.209055_bb0185","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2023.209055_bb0190","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2023.209055_bb0195","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. HHS Publication No. PEP21-07-01-003","first-page":"156","year":"2021"},{"key":"10.1016\/j.josat.2023.209055_bb0200","series-title":"Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63. Publication No. PEP21-02-01-002","volume":"332","year":"2021"},{"key":"10.1016\/j.josat.2023.209055_bb0205","series-title":"Medications for the Treatment of Opioid Use Disorder","year":"2022"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0210","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/08897077.2022.2060438","article-title":"\u201cThe idea is to help people achieve greater success and liberty\u201d: A qualitative study of expanded methadone take-home access in opioid use disorder treatment","volume":"43","author":"Suen","year":"2022","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"issue":"2","key":"10.1016\/j.josat.2023.209055_bb0220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1834-7819.2002.tb00311.x","article-title":"Impact of opioid use on dentistry","volume":"47","author":"Titsas","year":"2002","journal-title":"Australian Dental Journal"},{"issue":"6","key":"10.1016\/j.josat.2023.209055_bb0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"International Journal for Quality in Health Care"},{"issue":"1","key":"10.1016\/j.josat.2023.209055_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic","volume":"45","author":"Williams","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"7","key":"10.1016\/j.josat.2023.209055_bb0235","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1360-0443.1996.917105311.x","article-title":"High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia","volume":"91","author":"Zador","year":"1996","journal-title":"Addiction (Abingdon, England)"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:28Z","timestamp":1762652368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":47,"alternative-id":["S2949875923001054"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209055","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209055"}}